Product image of Heparin Sodium Auxilia (Heparin Sodium) supplied by GNH India

Heparin Sodium Auxilia

Active Ingredient:
Heparin Sodium
Origin:
EU

Heparin Sodium Auxilia (Heparin Sodium)

Heparin Sodium Auxilia is a prescription‑only intravenous anticoagulant containing the active ingredient heparin sodium. Marketed in the European Union, it belongs to the antithrombotic class (ATC B01AB01) and works by potentiating antithrombin III, which inhibits thrombin and factor Xa, reducing clot formation. The product is intended for administration by a qualified health professional via slow IV infusion. It is supplied only with a prescription and requires careful monitoring of coagulation parameters.

Manufacturer / TM Owner

Gilvasan Pharma Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Heparin Sodium Auxilia is used in clinical settings where rapid anticoagulation is required.

  • Prevention and treatment of deep vein thrombosis (DVT) in at‑risk patients.
  • Prevention and treatment of pulmonary embolism (PE) following thromboembolic events.
  • Anticoagulation during cardiac surgery, coronary artery bypass grafting, and other invasive procedures.
  • Management of acute coronary syndromes, including unstable angina and non‑ST elevation myocardial infarction.
  • Prophylaxis of clot formation in patients undergoing hemodialysis or vascular catheterization.

Side Effects

Adverse reactions to Heparin Sodium Auxilia can be categorized by frequency and clinical significance.

Common

  • Minor bleeding at the injection site or from mucous membranes.
  • Transient elevation of liver enzymes.
  • Mild thrombocytopenia (moderate drop in platelet count).

Serious

  • Heparin‑induced thrombocytopenia (HIT) with risk of new thrombosis.
  • Major hemorrhage such as gastrointestinal or intracranial bleeding.
  • Allergic reactions including urticaria, angioedema, or anaphylaxis.

Precautions & Warnings

Before initiating therapy with Heparin Sodium Auxilia, clinicians should consider several precautionary measures.

  • Assess baseline coagulation status (aPTT, platelet count) and renal function.
  • Avoid use in patients with known hypersensitivity to heparin or pork‑derived products.
  • Monitor for signs of bleeding throughout treatment.
  • Adjust dose in patients with active bleeding or high bleeding risk.
  • Be vigilant for heparin‑induced thrombocytopenia, especially after 5–10 days of therapy.
  • Use lower initial doses in elderly or low‑body‑weight patients.

Avoid Interactions

Heparin Sodium Auxilia may interact with other agents that affect hemostasis or drug metabolism.

Avoid

  • Concurrent use with other anticoagulants (e.g., warfarin, direct oral anticoagulants) increases bleeding risk.
  • Combined therapy with antiplatelet drugs (aspirin, clopidogrel) should be avoided unless clinically justified.

Use with caution

  • Non‑steroidal anti‑inflammatory drugs (NSAIDs) may potentiate bleeding.
  • Thrombolytic agents (tPA, streptokinase) require close monitoring.
  • High‑dose corticosteroids can affect platelet function.
  • Drugs that alter renal clearance may modify heparin elimination.

Frequently Asked Questions

Heparin Sodium Auxilia potentiates antithrombin III, which inhibits thrombin (Factor IIa) and Factor Xa, thereby reducing the formation of fibrin clots.

It is commonly prescribed for prevention and treatment of deep vein thrombosis, pulmonary embolism, anticoagulation during cardiac or other invasive surgeries, and management of acute coronary syndromes.

The product is administered intravenously, typically as a slow infusion under the supervision of a qualified health professional.

Regular monitoring of activated partial thromboplastin time (aPTT), platelet counts, and signs of bleeding is recommended to ensure therapeutic effectiveness and safety.

No, patients with known hypersensitivity to heparin or pork‑derived products should not receive Heparin Sodium Auxilia.

Signs of HIT include a sudden drop in platelet count (usually >50% from baseline) occurring 5–10 days after initiation, accompanied by new thrombotic events.

Combining with aspirin or other antiplatelet agents increases bleeding risk and should be avoided unless the clinical benefit outweighs the risk.

If major bleeding occurs, the infusion should be stopped immediately and appropriate measures such as protamine sulfate administration and supportive care should be initiated.

Mild, transient elevations in liver enzymes have been reported, but they are usually not clinically significant.

Elderly or low‑body‑weight patients may require lower initial doses and closer monitoring of coagulation parameters to reduce bleeding risk.

Yes, it can be used as an anticoagulant during hemodialysis to prevent clotting of the extracorporeal circuit.

The ATC code for Heparin Sodium Auxilia is B01AB01, indicating it belongs to the class of antithrombotic agents.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Heparin Sodium

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT